BioVoice News December 2017-January 2018 Issue 7 Volume 2 | Page 12

cover story ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: develop an injectable vaccine that protects against all four dengue strains endemic to India. Vaccine for malaria caused by Plasmodium falciparum is under toxicology assessment (JAIVAC 2) and another vaccine for malaria caused by Plasmodium vivax has completed Phase I trial (JAIVAC1). 12 BioVoiceNews | Dec 2017 - Jan 2018 water, soil, seed and marketing, with validated technologies. This programme is also A new, farmer-centric expected to create a programme called strong interaction ‘Biotech-KISAN’ was platform between announced that would scientists and farmers. create a major impact The programme also on rural livelihood. The includes thematic objective of the fellowships in science programme is to laboratories located demonstrate, scale-up across all the agro- and address issues of climatic zones. local farmers related to A lOOk At kEY BIOtECh pOlICY dECISIONS